(Q40746248)

23 September 2017

title

Construction, purification and characterization of adenovirus vectors expressing apoptosis-inducing transgenes (English)

1 reference

23 September 2017

1 reference

Semyon Rubinchik

1

1 reference

23 September 2017

James S Norris

series ordinal

2

1 reference

23 September 2017

Jian-Yun Dong

series ordinal

3

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

23 September 2017

published in

Methods in Enzymology

1 reference

23 September 2017

volume

346

1 reference

23 September 2017

page(s)

529-547

1 reference

Restricted expression of an adenoviral vector encoding Fas ligand (CD95L) enhances safety for cancer gene therapy

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946075-2

7 January 2021

Efficient Fas-ligand gene expression in rodent liver after intravenous injection of a recombinant adenovirus by the use of a Cre-mediated switching system

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946075-2

7 January 2021

Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946075-2

7 January 2021

Development and use of a 293 cell line expressing lac repressor for the rescue of recombinant adenoviruses expressing high levels of rabies virus glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946075-2

7 January 2021

Methods for construction of adenovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946075-2

7 January 2021

Adenovirus vector technology: an efficient method for constructing recombinant adenovirus and on/off switching of gene expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946075-2

7 January 2021

Construction of a Double Recombinant Adenovirus Vector Expressing a Heterodimeric Cytokine: In Vitro and In Vivo Production of Biologically Active Interleukin-12

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946075-2

7 January 2021

Use of the cosmid adenoviral vector cloning system for the in vitro construction of recombinant adenoviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946075-2

7 January 2021

Generation of recombinant adenovirus vector with infectious adenoviral genome released from cosmid-based vector by simple procedure allowing complex manipulation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946075-2

7 January 2021

A high-efficiency Cre/loxP-based system for construction of adenoviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946075-2

7 January 2021

A simple method for the rapid generation of recombinant adenovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946075-2

7 January 2021

Modulation of the specificity and activity of a cellular promoter in an adenoviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946075-2

7 January 2021

Creation of a new transgene cloning site near the right ITR of Ad5 results in reduced enhancer interference with tissue-specific and regulatable promoters

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946075-2

7 January 2021

Use of enhanced green fluorescent protein to optimize and quantitate infection of target cells with recombinant retroviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946075-2

7 January 2021

Adenoviral vector which delivers FasL-GFP fusion protein regulated by the tet-inducible expression system

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946075-2

7 January 2021

Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946075-2

7 January 2021

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946075-2

7 January 2021

FasL induces Fas/Apo1-mediated apoptosis in human embryonic kidney 293 cells routinely used to generate E1-deleted adenoviral vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946075-2

7 January 2021

Inhibition of apoptosis and clonogenic survival of cells expressing crmA variants: optimal caspase substrates are not necessarily optimal inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946075-2

7 January 2021

The baculovirus p35 protein inhibits Fas- and tumor necrosis factor-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946075-2

7 January 2021

IRES bicistronic expression vectors for efficient creation of stable mammalian cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946075-2

7 January 2021

IRES elements: fine-tuning of gene expression at the translational level

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946075-2

7 January 2021

Supernatant rescue assay vs. polymerase chain reaction for detection of wild type adenovirus-contaminating recombinant adenovirus stocks

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946075-2

7 January 2021

Modulation of growth and apoptosis response in PC-3 and LNCAP prostate-cancer cell lines by Fas

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946075-2

7 January 2021

10.1016/S0076-6879(02)46075-2

Identifiers

DOI

1 reference

23 September 2017

1 reference